Not Signed In - Cognitive function and compliance with Seroquel® examined in separate studies in schizophrenia
Mon, 23 May 2005 06:00 PM EST
... AstraZeneca (NYSE: AZN) today announced results from a clinical study that examined the effectiveness of SEROQUEL and risperidone in improving cognitive function, such as memory and attention, in patients with schizophrenia... click link for more info. ...
Related Topics
- Schizophrenia
- Cognitive behavior therapy
- Loss of cognitive function
- Platelet Function
- Dopamine
- Tests for Kidney Function
- Paranoid Schizophrenia
- Schizophrenia - disorganized type
- Cognitive Restructuring
- Mild cognitive impairment
- Kidney Function-normal
- Traumatic Brain Injury: Cognitive and Communication Disorders
- Other neurological problems (such as vision changes, difficulty speaking, or cognitive decline)
- Teen Development
- Asian American
- Reduced lung function
- Inability to function or care for self
- Acquired platelet function defect
- Loss of ability to function or care for self
- Congenital platelet function defects
email this page
print this page
bookmark this page
feedback on this page
